In Depth 13 Dec 2024
Is China the future of biotech?
Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context.
investment
- Latest Posts
More News! 10 Dec 2024
Biotech in 2024: A retrospective
2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?
Podcast 6 Dec 2024
Cracking the code of biotech valuations
Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom.
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
In Depth 18 Nov 2024
What is Abcam’s founder, Jonathan Milner, up to?
Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy.
Expert Advice 15 Nov 2024
How biotech startups become unicorns
Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation.
ADVERTISEMENT
ADVERTISEMENT
Podcast 15 Nov 2024
Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases
This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI).
In Depth 11 Nov 2024
Gene editing sector investment struggles: What’s driving the slowdown?
Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs.
In Depth 7 Nov 2024
The biggest private biotech investments in October 2024
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.
In Depth 5 Nov 2024
From consumer health to pure biopharma: Inside Sanofi’s strategic shift
Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment.
In Depth 4 Oct 2024
The biggest private biotech investments in September 2024
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.
News and Trends 12 Sep 2024
Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges
Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.
ADVERTISEMENT
